The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global ginseng extract market grew at a CAGR of around 5% during 2015-2020. Looking forward, IMARC Group expects the market to exhibit moderate growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
Panax ginseng refers to a perennial plant found across Eastern Asia and North America that has an oval-shaped root, namely ginseng. This root is dried and processed to obtain ginseng extract that is widely used as a healthy substitute. Comprising high levels of bioactive compounds, including salicylic acid, vanillic acid, phenolic acids maltol, and p-coumaric acid, it is widely available in the market in numerous forms, such as fresh ginseng, red ginseng and white ginseng. It is characterized by anti-cancer, anti-inflammatory and antioxidant properties due to which it is increasingly being used as an essential component in the formulation of multiple pharmaceutical drugs, foods and beverage, dietary supplements, and cosmetics and personal care products.
The global market is primarily driven by the increasing awareness regarding the health benefits offered by the consumption of ginseng extract. This adaptogenic substance comprises ginsenosides, a class of natural product steroid glycosides and triterpene saponins, that provide insulin resistance reduction, immunomodulating properties and antidiabetic effects. This has led to the rising utilization of the extract in the preparation of multiple refreshing drinks and East Asian foods. Supported by the growing preference among the masses to lead a healthy lifestyle and their shifting dietary preferences, this is providing a thrust to the market growth. Moreover, the innumerable health benefits offered by ginseng extract has led to its widespread utilization in the pharmaceutical sector for the formulation of several drugs, along with their increasing applications in the production of nutraceuticals and dietary supplements. The market is further driven by the rising preference for natural and organic skincare and personal care products across the globe. This has impelled the increasing utilization of natural extracts, including ginseng, to form an essential component in the production of numerous creams, lotions and face masks. Facilitated by the easy product availability through online and offline retail channels, this is creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global ginseng extract market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on form and application.
Breakup by Form:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Baoji Herbest Bio-Tech, Changsha Huir Biological-Tech, Clariant AG, Hangzhou Skyherb, KGEC, Koei Kogyo, Naturalin Bio-Resources Co. Ltd., Nino Biotech, Orkla Health, RFI ingredient, Shanti Natural and Sinochem Pharmaceutical.
|Base Year of the Analysis||2020|
|Segment Coverage||Form, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Baoji Herbest Bio-Tech, Changsha Huir Biological-Tech, Clariant AG, Hangzhou Skyherb, KGEC, Koei Kogyo, Naturalin Bio-Resources Co. Ltd., Nino Biotech, Orkla Health, RFI ingredient, Shanti Natural and Sinochem Pharmaceutical|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at